Retinol binding protein-4 is associated with TNF-\alpha and not insulin resistance in subjects with type 2 diabetes mellitus and coronary heart disease

Disease Markers

Volumn 26, Issue 3, 2009, Pages 135-140

  Al Daghri, Nasser M ^a   Al Attas, Omar S ^a   Alokail, Majed ^a   Draz, Hossam M ^a   Bamakhramah, Ahmed ^a   Sabico, Shaun ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Coronary heart diseases; Insulin resistance; Retinol binding protein 4; TNF ; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LEPTIN; METFORMIN; RESISTIN; RETINOL BINDING PROTEIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LOW CARBOHYDRATE DIET; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 68649117416     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/725948     Document Type: Article

References (30)

1. S.M. Grundy, Obesity, metabolic syndrome, and cardiovascular disease, J Clin Endocrinol Metab 89 (2004), 2595-2600.
2. R. Beetham, A. Silver and A. Dawnay, Urinary albumin and retinol-binding protein in diabetes, Clin Chem 33 (1987), 713.
3. Q. Yang, T.E. Graham, N. Mody, F. Preitner, O.D. Peroni, J.M. Zabalotny, K. Kotani, L. Quadro and B.B. Khan, Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes, Nature 436(7049) (2005), 356-362.
4. Y. Tamori, H. Sakaue and M. Kasuga, RBP4, an unexpected adipokine, Nat Med 12 (2006), 30-31.
5. C.G. Basualdo, E.E. Wein and T.K. Basu, Vitamin A (retinol) status of first nation adults with non insulin-dependent diabetes mellitus, J Am Coll Nutr 16 (1997), 39-45.
6. M.A. Abahusain, J. Wright, J.W. Dickerson and E.B. de Vol, Retinol, alphatocopherol and carotenoids in diabetes, Eur J Clin Nutr 53 (1999), 630-635.
7. T.E. Graham, Q Yang, M, Bluher, A. Hammarstedt, T.P. Cia-raldi, R.R. Henry, C.J. Wason, A. Oberbac, P.A. Jansson, U. Smith and B.B. Kahn, Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects, N Engl J Med 354 (2006), 2552-2563.
8. J. Janke, S. Engeli, M. Boschmann, F. Adams, J. Bohnke, F.C. Luft, A.M. Sharma and J. Jordan, Retinol-binding protein 4 in human obesity, Diabetes 55 (2006), 2805-2810.
9. C. Erikstrup, O.H. Mortensen and B.K. Pedersen, Retinol-binding protein 4 and insulin resistance, N Engl J Med 355 (2006), 1393-1394.
10. Y.M. Cho, B.S. Youn, H. Lee, N. Lee, S.S Min, S.H. Kwak, H.K Lee and K.S. Park, Plasma retinol binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes, Diabetes Care 29 (2006), 2457-2461.
11. M. von Eynatten, P.M. Lepper, D. Liu, K. Lang, M. Baumann, P.P. Nawroth, A. Bierhaus, K.A. Dugi, U.Heemann, B. Allolio and P.M. Humpert, Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease, Diabetologia 50 (2007), 1930-1937.
12. G.S. Hotamisligil, N.S. Shargill and B.M. Spiegelman, Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance, Science 259 (1993), 87-91.
13. H. Sell and J. Eckel, Regulation of retinol binding protein 4 production in primary human adipocytes by adiponectin, troglitazone and TNF-alpha, Diabetologia 50(10) (2007), 2221-2223.
14. D.R. Matthews, A.S. Rudenski, B.A. Naylor, D.F. Treacher and R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia 28(7) (1985), 412-419.
15. I. Kowalska, M. Straczkowski, A. Adamska, A. Nikolajuk, M. Karczewska-Kupczewska, E. Otziomek and M. Gorska, Serum retinol binding protein 4 is related to insulin resistance and nonoxidative glucose metabolism in lean and obese women with normal glucose tolerance, J Clin Endocrinol Metab 93(7) (2008), 2786-2789.
16. M. Vitkova, E. Klimcakova, M. Kovacikova, C. Valle, C. Mo-ro, J. Polak, J. Hanacek, F. Capel, N. Viguerie, B. Richterova, M. Bajzova, J. Hejnova, V. Stich and D. Langin, Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity, J Clin Endocrinol Metab 92(6) (2007), 2330-2335.
17. S. Xu and P. Venge, Lipocalins as biochemical markers of disease, Biochim Biophys Acta 1482 (2000), 298-307.
18. S. Gavi, L.M. Stuart, P. Kelly, M.M. Melendez, D.C. Mynar-cik, M.C. Gelato and M.A. McNurlan, Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes, J Clin Endocrinol Metab 92 (2007), 1886-1890.
19. L. Munkhtulga, K. Nakayama, N. Utsumi, Y. Yanagisawa, T. Gotoh, T. Omi, M. Kumada, B. Erdenebulgan, K. Zolzaya, T. Lkhagvasuren and S. Iwamoto, Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in Mongolia, Hum Genet 120 (2007), 879-888.
20. N. Takashima, H. Tomoike and N. Iwai, Retinol-binding protein 4 and insulin resistance, N Engl J Med 355 (2006), 1392.
21. J.G. Lewis, B.I. Shand, C.M. Frampton, P.A. Elder and R.S. Scott, Plasma retinol-binding protein is not a marker of insulin resistance in overweight subjects: a three year longitudinal study, Clin Biochem 41(13) (2008), 1034-1038.
22. A. Henze, S.K. Frey, J. Raila, M. Tepe, A. Scholze, A.F. Pfeif-fer, M.O. Weickert, J. Spranger and F.J. Schweigert, Evidence that kidney function but not type 2 diabetes mellitus determines retinol-binding protein 4 (RBP4) serum levels, Diabetes 57(12) (2008), 3323-3326.
23. J. Rosenstock, J. Rood, A. Cobitz, N. Biswas, H. Chou and A. Garber, Initial treatment with rosiglitazone/metformin fixed-dose therapy compared with monotherapy with either rosigli-tazone or metformin in patients with uncontrolled type 2 diabetes, Diabetes, Obesity and Metabolism 8 (2006), 650-660.
24. P.A. Kern, M. Saghizadeh, J.M. Ong, R.J. Bosch, R. Deem and R.B. Simsolo, The expression of tumor necrosis factor in human adipose tisssue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase, J Clin Invest 95 (1995), 2111-2119.
25. G.S. Hotamisligil, P.Peraldi, A.Budavari, R. Ellis, M.F. White and B.M. Spiegelman, IRS1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-a- and obesity-induced insulin resistance, Science 271 (1996), 665-668.
26. M. Saghizadeh, J.M. Ong, W.T. Garvey, R.R. Henry and P.A Kern, The expression of TNFa by human muscle. Relationship to insulin resistance, J Clin Invest 97 (1996), 1111-1116.
27. H.A. Koistinen, J.P. Bastard, E. Dusserre, P. Ebeling, N. Ze-gari, F. Andreelli, C. Jardel, M. Donner, L. Meyer, P. Moulin, B. Hainque, J.P. Riou, M. Laville, V.A. Koivisto and H. Vidal, Subcutaneous adipose tissue expression of tumour necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects, Eur J Clin Invest 30 (2000), 302-310.
28. L.S. Liu, M. Spelleken, K. Rohrig, H. Hauner and J. Eckel, Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor, Diabetes 47 (1998), 515-522.
29. C. Erikstrup, O.H. Mortensen, A.R. Nielsen, C.P. Fischer, P. Plomgaard, A.M. Petersen, R. Krogh-Madsen, B. Lindegaard, J.G. Erhardt, H.Ullum, C.S. Benn and B.K. Pedersen, RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes, Diabetes, Obesity and Metabolism 11(3), 204-212.
30. T.E. Graham, C.J. Wason, M. Blüher and B.B. Kahn, Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects, Diabetologia, 50(4) (2007), 814-23